You have not verified your Email yet. Please verify your Email to create alerts
Verify Email
|
Lasa Supergenerics
|
Dishman Carbogen Amc
|
Gufic Biosciences
|
||
|---|---|---|---|---|
|
Operational Metrics
|
||||
|
Financials
|
||||
|
5 yr Average ROE
|
-6.11 % | 0.72 % | 26.14 % | |
|
5yr average Equity Multiplier
|
1.61 | 1.49 | 2.92 | |
|
5yr Average Asset Turnover Ratio
|
0.76 | 0.25 | 1.09 | |
|
5yr Avg Net Profit Margin
|
-5.47 % | 1.79 % | 9.03 % | |
|
Price to Book
|
1.11 | 0.44 | 8.01 | |
|
P/E
|
0.0 | 0.0 | 35.13 | |
|
5yr Avg Cash Conversion Cycle
|
20.11 Days | 42.6 Days | -18.02 Days | |
|
Inventory Days
|
51.19 Days | 101.13 Days | 77.22 Days | |
|
Days Receivable
|
29.63 Days | 80.42 Days | 81.36 Days | |
|
Days Payable
|
82.8 Days | 166.8 Days | 141.41 Days | |
|
5yr Average Interest Coverage Ratio
|
-17.38 | 2.31 | 10.3 | |
|
5yr Avg ROCE
|
1.63 % | 2.38 % | 33.27 % | |
|
5yr Avg Operating Profit Margin
|
11.3 % | 20.95 % | 17.37 % | |
|
5 yr average Debt to Equity
|
0.31 | 0.23 | 0.73 | |
|
5yr CAGR Net Profit
|
26.27 % | n/a | 29.43 % | |
|
5yr Average Return on Assets
|
-3.66 % | 0.54 % | 10.12 % | |
|
Shareholdings
|
||||
|
Promoter Holding
|
53.65 % | 59.32 % | 75.0 % | |
|
Share Pledged by Promoters
|
20.66 % | 0.0 | 0.0 | |
|
Change in Promoter Holding (3 Yrs)
|
-10.82 % | -3.89 % | 9.25 % | |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | -9.79 % | -6.88 % |
|
Lasa Supergenerics
|
Dishman Carbogen Amc
|
Gufic Biosciences
|
|
|---|---|---|---|
|
Segment Break-Up
|
Segment Break-Up
|
Segment Break-Up
|
-
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
